The GSK name and elements of the incumbent orange logo have been retained in the new identity. Stevens says that the decision to retain the orange was partly driven by the fact that “the world of ...

The logo also has a hidden message: The pink 31 in the logo stands for each ... is meant to be similar to that of a medical pill. GSK is a recently created company, formed out of a merger of ...

Designer Jill Martin was diagnosed with Stage 2 breast cancer in 2023. The NBA and WNBA logos are turning pink for Breast Cancer Awareness Month. Designer and breast cancer survivor Jill Martin ...

TOWN OF DICKINSON, N.Y. (WIVT/WBGH) – Broome County Sheriff’s Office Corrections Officers and Deputies will be adorned with a ...

Sept 11 (Reuters) - British drugmaker GSK (GSK.L), opens new tab said on Wednesday its experimental herpes simplex virus (HSV) vaccine candidate failed to meet the main goal of a mid-stage trial ...

The company has a new logo, designed by Pentagram, that looks incredibly plain — especially compared to previous iterations of the logo that featured a rakish slant, two shades of blue ...

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the ...

GSK’s vaccine portfolio. GSK’s portfolio of more than 20 marketed vaccines, one of the industry’s broadest, protects people against diseases such as meningitis, shingles, polio, measles ...

In a report released yesterday, Kerry Holford from Berenberg Bank maintained a Buy rating on GlaxoSmithKline (GSK – Research Report), with a price target of £18.20. The company’s shares ...

J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £15.50. The company’s shares opened today at p1,644. ...

Partnership is integral to GSK. Bringing people together is the best way to innovate and deliver products that transform the standard of care and improve lives. Over half of GSK’s clinical ...